IntegraGen
Latest round
- Series B
Last raised
- Nov 2005
Total raised
- $9.7M
Investors
- 5
About IntegraGen
IntegraGen SA was founded in 2000 and is headquartered in France. The company engages in genomic testing and bioinformatics, providing valuable insights for research institutions and biopharmaceutical companies. Eric Letouzé is the founder, and Bernard Courtieu serves as the CEO.IntegraGen specializes in genomic testing and data analysis software tailored for researchers and clinicians in oncology and rare genetic diseases. Their main offerings include next-generation sequencing services, custom bioinformatics, and biostatistical tools, enabling effective genomic data analysis.60. The company's revenue model focuses on providing genomic testing and bioinformatics services on a B2B basis, primarily to research institutions and biopharmaceutical firms.IntegraGen is focused on developing new products that leverage advancements in genomic technology, with plans to introduce these products in upcoming quarters. Additionally, the company aims to expand its market presence into new geographic regions, including Asia and South America, by 2025.
Who invested in IntegraGen
5 investors across 1 round
See all investors in IntegraGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 1, 2005
Amount
$9.7M
Investors
Questions about IntegraGen
Who invested in IntegraGen?
IntegraGen has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IntegraGen raised?
IntegraGen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did IntegraGen last raise money?
IntegraGen's most recent round on record is a Series B, in Nov 2005.
What does IntegraGen do?
IntegraGen SA was founded in 2000 and is headquartered in France.
Where is IntegraGen headquartered?
IntegraGen is headquartered in France.
Which VCs invest in companies like IntegraGen?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at IntegraGen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like IntegraGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.